Kenneth Wang, MD, director of the Advanced Endoscopy Group and Esophageal Neoplasia Clinic, Mayo Clinic, discusses his opposition for Barrett's esophagus screening as a preventative measure for esophageal adenocarcinoma.
'Kenneth Wang, MD, director of the Advanced Endoscopy Group and Esophageal Neoplasia Clinic, Mayo Clinic, discusses his opposition for screening for Barrett's esophagus as a preventative measure for esophageal adenocarcinoma. Wang says currently, a gastroenterologist will most commonly screen a patient for Barrett's esophagus with an endoscopy. Wang says the practice of endoscopies do not result in many revelations of Barrett's esophagus, partially due to not enough biopsies being taken.
UGN-101 Shows Promise for Upper Tract Urothelial Cancer Durability
May 5th 2024Maintenance UGN-101 therapy demonstrated good durability of response in initial responders with low-grade upper tract urothelial cancer, as evidenced by a low rate of disease progression in a multicenter, longitudinal follow-up study.
Read More